000 01463 a2200445 4500
005 20250513133844.0
264 0 _c19980205
008 199802s 0 0 eng d
022 _a0003-4932
024 7 _a10.1097/00000658-199801000-00015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWerner, J
245 0 0 _aThe relative safety of MRI contrast agent in acute necrotizing pancreatitis.
_h[electronic resource]
260 _bAnnals of surgery
_cJan 1998
300 _a105-11 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aDrug Monitoring
650 0 4 _aErythrocytes
650 0 4 _aGadolinium DTPA
_xpharmacokinetics
650 0 4 _aHemodynamics
_xdrug effects
650 0 4 _aIsothiocyanates
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aMale
650 0 4 _aMicrocirculation
_xdrug effects
650 0 4 _aPancreatitis, Acute Necrotizing
_xdiagnosis
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aSeverity of Illness Index
650 0 4 _aTomography, X-Ray Computed
_xadverse effects
700 1 _aSchmidt, J
700 1 _aWarshaw, A L
700 1 _aGebhard, M M
700 1 _aHerfarth, C
700 1 _aKlar, E
773 0 _tAnnals of surgery
_gvol. 227
_gno. 1
_gp. 105-11
856 4 0 _uhttps://doi.org/10.1097/00000658-199801000-00015
_zAvailable from publisher's website
999 _c9414341
_d9414341